PTeye in Parathyroid Adenoma | Clinical Trial

Key information

Conditions

Parathyroid Adenoma Endocrine Gland Neoplasms Endocrine System Diseases Head and Neck Neoplasms Neoplasms Neoplasms by Site Parathyroid Diseases Parathyroid Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Aristotle Univeristy of Thessaloniki

Thessaloniki, 54636, Greece

Location status: Recruiting

About this study

Identifying the parathyroids is compulsory for success of parathyroidectomy for parathyroid adenoma. Near-infrared autofluorescence devices have been proposed as useful intraoperative tools for the identification of parathyroid glands. Two approaches are available to surgeons to perform near-infrared autofluorescence: (i) Camera-based systems (CBS) and (ii) Probe-based systems such as PTeye™ (Medtronic, Minneapolis, MN).The aim of the present study is to evaluate the correlation of PTeye autofluorescence device with biochemical data of parathyroid adenoma patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age >18 years old
primary hyperparathyroidism caused by adenoma
patient's informed consent acquired

Exclusion criteria

Secondary and tertiary hyperparathyroidism
Re-operation for adenoma
Previous neck surgery
Patient enrolled in another study that may affect the results of this study

Treatment and study plan

Parathyroidectomy

Procedure

typical open parathyroidectomy

Primary outcomes

assess the correlation of PTeye values with biochemical data

Time frame: intraoperatively and 1st postoperative day

Biochemical data included are pre- and postoperative parathyroid hormone, serum calcium, phosphorus and vitamin D levels

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Aristotle University Of Thessaloniki

Other

Registry information

Official study title

Do PTeye Score Correlate With Biochemical Markers in Parathyroid Adenoma?

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Apr 6, 2025
Registry last updated: Apr 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting